;wherein R1 represents optionally substituted aryl, heteroaryl, arylalkyl, or cycloalkyl groups; X, Z, and Y are optionally substituted nitrogen or carbon atoms; R3 and R4 are organic or inorganic substituents which may together form ring structures; m is zero, one or two; and R5 and R6 are are organic or inorganic substituents;;and the pharmaceutically acceptable addition salts thereof,;which compounds are highly selective partial agonists or antagonists at brain dopamine receptor subtypes or prodrugs thereof and are useful in the diagnosis and treatment of affective disorders such as schizophrenia and depression as well as certain movement disorders such as Parkinsonism."/>
公开/公告号US6358955B1
专利类型
公开/公告日2002-03-19
原文格式PDF
申请/专利权人 NEUROGEN CORPORATION;
申请/专利号US20000497988
申请日2000-02-04
分类号A61K314/54;A61K314/96;A61K315/06;A61N251/80;A61N252/40;
国家 US
入库时间 2022-08-22 00:49:06